Huntington's disease: which drugs might help patients?

Anthony J. Hannan*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

22 Citations (Scopus)

Abstract

Huntington's disease (HD) is a fatal, genetically based brain disorder in which there is progressive neurodegeneration leading to motor, cognitive and psychiatric symptoms. The trinucleotide repeat mutation involved is common to many other brain diseases, and may therefore involve similar mechanisms of pathogenesis. We are beginning to understand how a CAG repeat expansion, encoding an expanded polyglutamine tract, induces progressive deficits in intra- and inter-cellular signaling, and subsequent disease symptoms. This review focuses on our current knowledge of molecular mechanisms of pathogenesis in HD and the use of this information to identify potential therapeutic targets and screen drugs in various transgenic models.

Original languageEnglish
Pages (from-to)351-358
Number of pages8
JournalIDrugs : the investigational drugs journal
Volume7
Issue number4
Publication statusPublished - Apr 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Huntington's disease: which drugs might help patients?'. Together they form a unique fingerprint.

Cite this